Suppr超能文献

儿童创伤患者急性呼吸窘迫综合征体外膜肺氧合治疗结局。

Outcomes of Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome in Pediatric Trauma Patients.

机构信息

Division of Trauma & Surgical Critical Care, Jersey Shore University Medical Center, Neptune, NJ.

Hackensack Meridian School of Medicine, Nutley, NJ.

出版信息

Crit Care Explor. 2024 Sep 10;6(9):e1150. doi: 10.1097/CCE.0000000000001150. eCollection 2024 Sep 1.

Abstract

IMPORTANCE

Acute respiratory distress syndrome (ARDS) is associated with high mortality and morbidity. Extracorporeal membrane oxygenation (ECMO) is one of the interventions that have been in practice for ARDS for decades.

OBJECTIVES

The purpose of the study was to investigate the outcomes of ECMO in pediatric trauma patients who suffered from ARDS.

DESIGN

Observational cohort study.

SETTING AND PARTICIPANTS

The Trauma Quality Improvement Program database for years 2017 to 2019 and 2021 through 2022 was accessed for the study. All children younger than 18 years old who were admitted to the hospital after trauma and suffered from ARDS were included in the study. Other variables included in the study were patients' demographics, clinical characteristics, Injury Severity Score (ISS), Glasgow Coma Scale (GCS) score, comorbidities, and outcomes.

MAIN OUTCOMES AND MEASURES

ECMO is the exposure, and the outcomes are in-hospital mortality and hospital complications (acute kidney injury [AKI], pneumonia and deep vein thrombosis [DVT]).

RESULTS

Of 453 patients who qualified for the study, propensity score matching found 50 pairs of patients. There were no significant differences identified between the groups, ECMO+ vs. ECMO- on patients' age in years (16 yr; interquartile range [IQR], 13.25-17 yr vs. 16 yr [14.25-17 yr]), race (White; 62.0% vs. 66.0%), sex (male; 78% vs. 76%), ISS (23 [IQR, 9.25-34] vs. 22 [9.25-32]), and GCS (15 [IQR, 3-15] vs. 13.5 [3-15]), mechanism of injury; and comorbidities. There was no difference between the groups, ECMO+ vs. ECMO-, in-hospital mortality (10.0% vs. 20.0%; p = 0.302), hospital complications (AKI 12.0% vs. 2.0%; p = 0.131), pneumonia (10.0% vs. 20.0%; p = 0.182 > ), and DVT (16% vs. 6%; p = 0.228).

CONCLUSIONS AND RELEVANCE

No difference in mortality was observed in injured children who suffered from the ARDS and were placed on ECMO when compared with patients who were not placed on ECMO. Patients with trauma and ARDS who require ECMO have comparable outcomes to those who do not receive ECMO. A larger sample size study is needed to find the exact benefit of ECMO in this patients' cohort.

摘要

重要性

急性呼吸窘迫综合征(ARDS)与高死亡率和高发病率相关。体外膜肺氧合(ECMO)是几十年来用于 ARDS 的干预措施之一。

目的

本研究旨在调查 ECMO 在患有 ARDS 的儿科创伤患者中的结局。

设计

观察性队列研究。

地点和参与者

研究使用了 2017 年至 2019 年以及 2021 年至 2022 年的创伤质量改进计划数据库。所有年龄在 18 岁以下、因创伤后住院且患有 ARDS 的儿童均纳入本研究。研究中还包括其他变量,如患者的人口统计学特征、临床特征、损伤严重程度评分(ISS)、格拉斯哥昏迷评分(GCS)、合并症和结局。

主要结果和措施

ECMO 是暴露因素,结局为院内死亡率和医院并发症(急性肾损伤[AKI]、肺炎和深静脉血栓形成[DVT])。

结果

在符合研究条件的 453 名患者中,通过倾向评分匹配找到了 50 对患者。ECMO+组与 ECMO-组在患者年龄(16 岁;四分位距[IQR],13.25-17 岁比 16 岁[14.25-17 岁])、种族(白人;62.0%比 66.0%)、性别(男性;78%比 76%)、ISS(23[IQR,9.25-34]比 22[9.25-32])和 GCS(15[IQR,3-15]比 13.5[3-15])、损伤机制和合并症方面无显著差异。ECMO+组与 ECMO-组在院内死亡率(10.0%比 20.0%;p=0.302)、医院并发症(AKI 12.0%比 2.0%;p=0.131)、肺炎(10.0%比 20.0%;p=0.182)>)和 DVT(16%比 6%;p=0.228)方面无差异。

结论和相关性

与未接受 ECMO 的患者相比,因 ARDS 而接受 ECMO 的创伤患儿死亡率无差异。需要 ECMO 的创伤合并 ARDS 患者与未接受 ECMO 的患者具有相似的结局。需要更大的样本量研究来确定 ECMO 在该患者队列中的确切获益。

相似文献

本文引用的文献

6
Extracorporeal life support in pediatric trauma: a systematic review.小儿创伤中的体外生命支持:一项系统综述
Trauma Surg Acute Care Open. 2019 Sep 13;4(1):e000362. doi: 10.1136/tsaco-2019-000362. eCollection 2019.
7
Extracorporeal membrane oxygenation support in pediatrics.儿科体外膜肺氧合支持
Ann Cardiothorac Surg. 2019 Jan;8(1):109-115. doi: 10.21037/acs.2018.09.08.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验